Home


Strategic Consultation

Production-Service and Research

Protein Products

Peptide Production

Assay Development

Proteos Leadership

About Us

Contact Us
Strategic
Consultation
Production-Service
and Research
Protein Products Peptide Production Assay Development Proteos
Leadership
About
Us
Contact
Us

About Us

Quality Assurance Confidentiality Intellectual Property


Proteos Recognized
   

Michigan Governor Jennifer Granholm congratulates Proteos Founders, Drs. Robert Heinrikson(r) and Clark Smith(l)

Proteos, Inc. has been recognized as one of the "Michigan 50 Companies to Watch," an awards program sponsored by the Edward Lowe Foundation. Proteos received the honor at awards ceremonies during the second annual Michigan Celebrates Small Business event, April 19 in East Lansing.

"Michigan 50 Companies to Watch" is a unique awards program designed to shine the spotlight on second-stage companies," says Edward Lowe Foundation Executive Director Mark Lange. The Edward Lowe Foundation is a not-for-profit operating foundation based in Michigan. Its mission is to "champion the entrepreneurial spirit" by helping second-stage entrepreneurs learn from each other.

Companies nominated to be members of the "Michigan 50 Companies to Watch" list must be second-stage companies, defined as employing 6 to 99 full-time-equivalent employees and generating $750,000 to $50 million in annual revenue or working capital in place from investors or grants. In addition, the companies must be privately held and headquartered in Michigan.

Winners were selected by representatives of the Michigan Small Business & Technology Development Center, the Small Business Association of Michigan, the Michigan Economic Development Corporation, the U.S. Small Business Administration-Michigan, the Michigan Certified Development Corporation and the Edward Lowe Foundation.


Quality Assurance
With each protein or peptide you will receive analytical data attesting to its state of purity. In addition to the usual SDS-PAGE and HPLC analytical systems, N-terminal sequencing and mass spectroscopy will be applied to assess the state of purity. We are committed to providing proteins and peptides at a level of purity that meets or exceeds customer specifications.

 

 

Confidentiality
Proteos holds all customer information and materials in strict confidence, whether it be in regard to strategic consultation or in the performance of a contract for protein production.

 

 

Intellectual Property
Proteos is seeking partnerships with academic investigators or commercial companies in joint efforts on early stage protein therapeutic agents where we would perform the translational research necessary to take a promising idea on toward a drug. We are currently partnering with academic researchers and other companies to fund and perform translational research through Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) grants. We would be interested in hearing about your early stage protein therapeutic project.

 


 

 

Back to Top ^


Proteos
Southwest Michigan Innovation Center
4717 Campus Drive
Kalamazoo, MI 49008
Phone: 269.372.3423
Fax: 269.353-5550
E-mail:
Home | Strategic Consultation | Production-Service and Research | Protein Products | Peptide Production | Assay Development
Proteos Leadership | About Us | Contact Us